............ 31 5.3 Emergency Unblinding of Treatment Assignment ................................ ................................ ......31 Heat Biologics, Inc. Investigational Product: Vesigenurtacel -L Protocol HS410 -101 CONFIDENTIAL Version 8.0; 03 Feb 2016 Page 15 of 86 6.0 STUDY PROCEDURES ................................ ................................